Abstract
The burden of anxiety in patients with systemic lupus erythematosus (SLE) compared to those with other inflammatory rheumatological conditions is unclear. We aimed to compare the frequency and level of anxiety between patients with SLE, rheumatoid arthritis (RA), and gout and healthy individuals and explore independent predictors for anxiety in SLE patients. Consecutive patients with SLE, RA and gout and healthy individuals who were age and sex matched with the SLE group were evaluated for anxiety using the Hospital Anxiety and Depression Scale (HADS). Sociodemographic and disease-related variables were compared between all groups. Predictors for anxiety were studied by regression models, with construction of a prediction model for the presence of anxiety in SLE patients by the receiver operating characteristic (ROC) analysis. Amongst 271 subjects studied, 60 had lupus, 50 had gout, 100 had RA and 61 were healthy controls. The frequency and level of anxiety were significantly higher in SLE patients than patients with gout, RA and healthy controls. SLE per se was independently associated with higher HADS-anxiety score after controlling for potential confounders. Logistic regression model showed that higher damage accrual, higher cumulative glucocorticoid dose, depression and fewer regular medications predicted anxiety in SLE patients, with an accuracy of 90% by the ROC analysis.
Similar content being viewed by others
References
Lau CS, Mak A (2009) The socioeconomic burden of SLE. Nat Rev Rheumatol 5:400–404
Trager J, Ward MM (2001) Mortality and causes of death in systemic lupus erythematosus. Curr Opin Rheumatol 13:345–351
Cervera R, Khamashta MA, Font J et al (1999) Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. Med Baltim 78:167–175
Campbell R Jr, Cooper GS, Gilkeson GS (2008) Two aspects of the clinical and humanistic burden of systemic lupus erythematosus: mortality risk and quality of life early in the course of disease. Arthritis Rheum 59:458–464
Ruperto N, Buratti S, Duarte-Salazar C et al (2004) Health-related quality of life in juvenile-onset systemic lupus erythematosus and its relationship to disease activity and damage. Arthritis Rheum 51:458–464
Chesney BEA, LA MA C (2009) Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus. Arthritis Rheum 61:822–829
Nery FG, Borba EF, Viana VS et al (2008) Prevalence of depressive and anxiety disorders in systemic lupus erythematosus and their association with anti-ribosomal P antibodies. Prog Neuropsychopharmacol Biol Psychiatry 32:695–700
Tam LS, Wong A, Mok VC et al (2008) The relationship between neuropsychiatric, clinical, and laboratory variables and quality of life of Chinese patients with systemic lupus erythematosus. J Rheumatol 35:1038–1045
Lim L, Ron MA, Ormerod IE et al (1988) Psychiatric and neurological manifestations in systemic lupus erythematosus. Q J Med 66:27–38
Lim LC, Lee TE, Boey ML (1991) Psychiatric manifestation of systemic lupus erythematosus in Singapore. A cross-cultural comparison. Br J Psychiatry 159:520–523
Harboe E, Tjensvoll AB, Maroni S et al (2009) Neuropsychiatric syndromes in patients with systemic lupus erythematosus and primary Sjögren syndrome: a comparative population-based study. Ann Rheum Dis 68:1541–1546
Líndal E, Thorlacius S, Steinsson K, Stefánsson JG (1995) Psychiatric disorders among subjects with systemic lupus erythematosus in an unselected population. Scand J Rheumatol 24:346–351
Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277
Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yü TF (1977) Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 20:895–900
Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324
Härter M, Woll S, Wunsch A, Bengel J, Reuter K (2006) Screening for mental disorders in cancer, cardiovascular and musculoskeletal diseases. Comparison of HADS and GHQ-12. Soc Psychiatry Psychiatr Epidemiol 41:56–62
Lam CL, Pan PC, Chan AW, Chan SY, Munro C (1995) Can the Hospital Anxiety and Depression (HAD) Scale be used on Chinese elderly in general practice? Fam Pract 12:149–154
Lam CL, Tse EY, Gandek B (2005) Is the standard SF-12 health survey valid and equivalent for a Chinese population? Qual Life Res 14:539–547
Gladman DD, Goldsmith CH, Urowitz MB et al (1992) Crosscultural validation and reliability of three disease activity indices in systemic lupus erythematosus. J Rheumatol 19:608–611
Gladman D, Ginzler E, Goldsmith C et al (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39:363–369
Yu LS, Chojniak R, Borba MA, Girão DS, Lourenço MT (2010) Prevalence of anxiety in patients awaiting diagnostic procedures in an oncology center in Brazil. Psychooncology. doi:10.1002/pon.1842
Collins MM, Corcoran P, Perry IJ (2009) Anxiety and depression symptoms in patients with diabetes. Diabet Med 26:153–161
Ozcan M, Uğuz F, Cilli AS (2006) The prevalence of generalized anxiety disorder and comorbidity among psychiatric outpatients. Türk Psikiyatri Derg 17:276–285
Chan YH (2004) Biostatistics 201: linear regression. Singapore Med J 45:55–61
Shortall E, Isenberg D, Newman SP (1995) Factors associated with mood and mood disorders in SLE. Lupus 4:272–279
Seguí J, Ramos-Casals M, García-Carrasco M et al (2000) Psychiatric and psychosocial disorders in patients with systemic lupus erythematosus: a longitudinal study of active and inactive stages of the disease. Lupus 9:584–588
Abdel-Nasser AM, Ghaleb RM, Mahmoud JA, Khairy W, Mahmoud RM (2008) Association of anti-ribosomal P protein antibodies with neuropsychiatric and other manifestations of systemic lupus erythematosus. Clin Rheumatol 27:1377–1385
Fones CS, Kua EH, Ng TP, Ko SM (1998) Studying the mental health of a nation: a preliminary report on a population survey in Singapore. Singapore Med J 39:251–255
Mella LF, Bértolo MB, Dalgalarrondo P (2010) Depressive symptoms in rheumatoid arthritis. Rev Bras Psiquiatr 32:257–263
Stebbings S, Herbison P, Doyle TC, Treharne GJ, Highton J (2010) A comparison of fatigue correlates in rheumatoid arthritis and osteoarthritis: disparity in associations with disability, anxiety and sleep disturbance. Rheumatol Oxf 49:361–367
Johnson JC, Gottlieb GL, Sullivan E et al (1990) Using DSM-III criteria to diagnose delirium in elderly general medical patients. Gerontol 45:M113–M119
Acknowledgement
We would like to thank the clinicians of the Department of Medicine, National University Health System, Singapore, for referral of patients who agreed to join the current studies.
Disclosures
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mak, A., Tang, C.SK., Chan, MF. et al. Damage accrual, cumulative glucocorticoid dose and depression predict anxiety in patients with systemic lupus erythematosus. Clin Rheumatol 30, 795–803 (2011). https://doi.org/10.1007/s10067-010-1651-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-010-1651-8